Trending Now
Aggressive Ways to Play the Infrastructure Bill (PXD, VMC, MLM, CEI,...
The momentum seems to be surprisingly on the side of the bipartisans in Congress – surprising, given the political context at present...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Stocks to Battle the Opioid Epidemic (NVRO, AXSM, EMED, MDT)
The opioid epidemic is a disaster.
Over 100 million Americans suffer from some form of chronic pain. Globally, experts believe the chronic pain market is...
MAKE IT MODERN
LATEST REVIEWS
Cellectar Biosciences Inc. (NASDAQ:CLRB) Receives Fast Track Designation For CLR 131...
Cellectar Biosciences Inc. (NASDAQ:CLRB) announced that the FDA has given Fast Track designation for CLR 131 in the treatment of Waldenstrom’s macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL)...
MAKE IT MODERN
PERFORMANCE TRAINING
Axovant Gene Therapies Ltd (NASDAQ:AXGT) Release Promising Cohort 2 of SUNRISE-PD Trial Data Of...
Axovant Gene Therapies Ltd (NASDAQ:AXGT) has reported its 6-month to follow-up data from the second group of patients who received a total dose of...
TriSalus Life Sciences Enters into an Asset Purchase Agreement under Which Dynavax Technologies Corporation...
TriSalus Life Sciences is on a mission to improve the lives of patients suffering from liver and pancreatic tumors. The company says that it...
Cybin Inc. (NYSEAMERICAN: CYBN) Announces Collaboration With The Chopra Foundation On Psychedelics-assisted Mental-Health Therapies
Cybin Inc. (NYSEAMERICAN: CYBN) and The Chopra Foundation have announced a collaboration to support awareness and education regarding innovative ways of harnessing the potential...
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) Announces its Plans for its Lead Product Candidate, Berubicin
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) has its lead product candidate, Berubicin being studied for the treatment of glioblastoma multiforme (GBM). A couple of months ago,...
OneMedNet (ONMD) Reports Impressive Five-Fold Revenue Increase
OneMedNet Corporation (NASDAQ: ONMD) has reported a remarkable five-fold increase in revenue for 2023, driven by the growing demand for its regulatory-grade...
MAKE IT MODERN
